Trial Details

Not recruiting
Basic Information
Clinical ID c3021
Identifier NCT02625259
Trial Title A Phase 1, Open-Label Study to Evaluate the Relative Bioavailability, Effect of Food, and Gastric pH Modification on the Pharmacokinetics of MLN1117 in Healthy Subjects
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Neoplasm, Advanced or Metastatic
Interventions Drug: MLN1117;Drug: Lansoprazole;Drug: MLN1117
Participant Information
Sponsor Millennium Pharmaceuticals, Inc.
City NULL
Country/Region NULL
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type Interventional
Phase PHASE1
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL